ZBP-89 reduces the cell death threshold in hepatocellular carcinoma cells by increasing caspase-6 and S phase cell cycle arrest

Cancer Lett. 2009 Sep 28;283(1):52-8. doi: 10.1016/j.canlet.2009.03.024. Epub 2009 Apr 11.

Abstract

ZBP-89 inhibits the some tumor cells but its role in HCC is unknown. We investigated effect of ZBP-89 on cell death of 5 HCC cell lines with different status of p53. We found that ZBP-89 significantly induced cell death of all HCC cells particularly those with wild-type p53. The inhibition was well correlated with the induction of caspase-6 activity. The inhibition of caspase-6 abolished the effect of ZBP-89. ZBP-89 reduced the cells in G2-M but increased them in S phase. With the changes in caspase-6 and cell cycle, ZBP-89 greatly enhanced the killing effectiveness of 5-fluorouracil or staurosporine in HCC cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Carcinoma, Hepatocellular / metabolism*
  • Caspase 6 / metabolism*
  • Cell Cycle / drug effects
  • Cell Cycle / physiology
  • Cell Death / drug effects
  • Cell Death / physiology
  • Cell Line, Tumor
  • DNA-Binding Proteins / metabolism*
  • Flow Cytometry
  • Fluorouracil / pharmacology
  • Humans
  • Liver Neoplasms / metabolism*
  • S Phase / drug effects
  • S Phase / physiology*
  • Staurosporine / pharmacology
  • Transcription Factors / metabolism*

Substances

  • Antineoplastic Agents
  • DNA-Binding Proteins
  • Transcription Factors
  • ZNF148 protein, human
  • Caspase 6
  • Staurosporine
  • Fluorouracil